Tag Archives: China in talks with Pfizer for generic Covid drug

HONG KONG: China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm’s Covid antiviral drug Paxlovid in China, three sources said. China’s medical products regulator — the National Medical Products Administration (NMPA) — has been leading the talks with Pfizer since late last …

Read More »